Study cohort began collecting data on newborns through adulthood, and may offer objective clues on asthma and COPD disease ...

Britain's blue-chip FTSE 100 kicked off the week higher on Monday, boosted by heavyweight healthcare and defence stocks, on ...

It forecasts that the repurchases - which are due to complete in 18 months - will boost core earnings by 6% to 8% in 2025 ...

The company's consolidated net profit jumped multifold to Rs 230 crore as compared to Rs 46 crore a year ago in the December ...

(HealthDay News) — The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active immunization against invasive meningococcal disease (IMD), ...

Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This ...

Broader markets also mirrored the benchmarks as the Nifty Smallcap100 and Nifty Midcap100 indices ended down by 1.02 per cent ...

Once people don’t have justifiable access to medicine, the disease will stay longer with those people. Some will end up dying ...

GSK Plc is looking to further grow its cancer drug business, a senior executive said, after the drugmaker’s $1.15 billion ...

The economy doesn’t need tweaks – it needs capitalist electric shock therapy. It needs a government brave enough to step back, to let capital do what it does best: build, innovate, grow and harvest ...

GSK plc has completed its previously announced acquisition of IDRx Inc., a Boston-based, clinical-stage biopharmaceutical ...

GSK (GSK) plc announced that it has completed the acquisition of IDRx, Inc., a Boston-based, clinical-stage biopharmaceutical company dedicated ...